61 related articles for article (PubMed ID: 30443716)
21. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study.
Hillemanns P; Breugelmans JG; Gieseking F; Bénard S; Lamure E; Littlewood KJ; Petry KU
BMC Infect Dis; 2008 Jun; 8():76. PubMed ID: 18518976
[TBL] [Abstract][Full Text] [Related]
22. New aspects of vulvar cancer: changes in localization and age of onset.
Hampl M; Deckers-Figiel S; Hampl JA; Rein D; Bender HG
Gynecol Oncol; 2008 Jun; 109(3):340-5. PubMed ID: 18407339
[TBL] [Abstract][Full Text] [Related]
23. [Vaccination: Protection for boys against genital warts and cancer via human papillomavirus infection].
Bühmann W
Urologe A; 2018 Dec; 57(12):1499-1508. PubMed ID: 30443716
[TBL] [Abstract][Full Text] [Related]
24. HPV vaccine update: new indications and controversies.
Mendoza N; Hernandez PO; Tyring SK
Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
26. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
Lehtinen M; Apter D
Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204
[TBL] [Abstract][Full Text] [Related]
27. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus and genital cancer.
Rapose A
Indian J Dermatol Venereol Leprol; 2009; 75(3):236-43; quiz 243-4. PubMed ID: 19439875
[TBL] [Abstract][Full Text] [Related]
29. Sexually Transmitted Human Papillomavirus: Update in Epidemiology, Prevention, and Management.
Plotzker RE; Vaidya A; Pokharel U; Stier EA
Infect Dis Clin North Am; 2023 Jun; 37(2):289-310. PubMed ID: 37105644
[TBL] [Abstract][Full Text] [Related]
30. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL; Joura EA
BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
[TBL] [Abstract][Full Text] [Related]
31. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus vaccination in the United Kingdom: what about boys?
Kubba T
Reprod Health Matters; 2008 Nov; 16(32):97-103. PubMed ID: 19027627
[TBL] [Abstract][Full Text] [Related]
33. HPV vaccines to prevent cervical cancer and genital warts: an update.
Dochez C; Bogers JJ; Verhelst R; Rees H
Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637
[TBL] [Abstract][Full Text] [Related]
34. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Pitisuttithum P; Velicer C; Luxembourg A
Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
[TBL] [Abstract][Full Text] [Related]
35. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention.
Forcier M; Musacchio N
Dermatol Ther; 2010; 23(5):458-76. PubMed ID: 20868401
[TBL] [Abstract][Full Text] [Related]
36. Genital human papillomavirus infections in adolescents: implications for evaluation and management.
Krowchuk DP; Anglin TM
Semin Dermatol; 1992 Mar; 11(1):24-30. PubMed ID: 1312856
[TBL] [Abstract][Full Text] [Related]
37. Counseling patients with genital warts.
Reitano M
Am J Med; 1997 May; 102(5A):38-43. PubMed ID: 9217661
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
Chelimo C; Wouldes TA; Cameron LD; Elwood JM
J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
[TBL] [Abstract][Full Text] [Related]
39. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
40. Harnessing the power of prevention: human papillomavirus vaccines.
Mayeaux EJ
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]